FDA Adverse Event Other Summary report: N

COAPTITE INJECTABLE IMPLANT

MDR report key: 1749431 · Received July 2, 2010

Report

Report Number
2135225-2010-00033
Event Type
Other
Date Received
July 2, 2010
Date of Event
February 24, 2009
Report Date
March 24, 2010
Manufacturer
BIOFORM MEDICAL, INC.
Product Code
LNM
PMA / PMN Number
P040047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LOT 1009317, EXP DATE: 04/01/2011, INJECTION DATES: (B)(6) 2008, (B)(6) 2009. DEVICE MFG DATE: 04/2008. THIS EVENT WAS REPORTED IN THE LINE LISTING OF THE INTERIM POST-APPROVAL STUDY STATUS REPORT FOR (B)(4), SUBMITTED TO THE FDA IN MARCH 2010. SINCE THE ADVERSE EVENT REQUIRED ANTIBIOTICS, IT WAS DETERMINED TO BE A REPORTABLE EVENT. THE DEVICE HISTORY RECORDS FOR COAPTITE LOTS 1009279 AND 1009317 WERE REVIEWED; ALL REQUIRED TESTING SPECIFICATIONS WERE MET PRIOR TO RELEASE AND THERE WERE NO ABNORMALITIES NOTED FOR EITHER LOT. THE COAPTITE LOT NUMBER FROM THE FIRST INJECTION ((B)(6) 2008) HAD NOT BEEN PROVIDED; QUERY FOR MOST PROBABLY LOT USED WILL BE CONDUCTED BY THE U.S.A. COAPTITE DISTRIBUTOR, BOSTON SCIENTIFIC CORP.

Description of Event or Problem · 1

COAPTITE POST APPROVAL STUDY. PT INJECTED WITH COAPTITE INJECTABLE IMPLANT FOR STRESS URINARY INCONTINENCE ON THREE SEPARATE OCCASIONS. THE FIRST OF 2.0ML COAPTITE WAS ON (B)(6) 2008, THE SECOND OF 2.0ML COAPTITE ON (B)(6) 2008, AND THE THIRD OF 3.0ML COAPTITE ON (B)(6)2009. THE PT DEVELOPED A URINARY TRACT INFECTION, ONCE WEEK AFTER THE THIRD INJECTION. THE PT WAS TREATED WITH ANTIBIOTICS FOR ONE WEEK AND THE UTI RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAPTITE INJECTABLE IMPLANT INJECTABLE IMPLANT LNM BIOFORM MEDICAL, INC. 1009279

Patients

Seq Age Sex Outcome Treatment
1 82 YR Required Intervention